HAMAD MEDICAL CORPORATION
🇶🇦Qatar
Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 170
- Registration Number
- NCT02868697
- Locations
- 🇶🇦
Fahd Bin Jassem Dialysis Centre, Doha, Qatar
PROspective Study to OPTimize thE HEALTH of Patients With TIAs (Transient Ischemic Attacks) and Stroke Admitted to the Hamad General Hospital
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT02868723
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Nurse Graduateness and Patient Outcomes: a Cross Sectional Pilot Study
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 1252
- Registration Number
- NCT02705001
Pharyngitis,Group A Streptococcal Infection,Rapid Streptococcal Test,Throat Swab Culture
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2015-07-10
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 906
- Registration Number
- NCT02494219
- Locations
- 🇶🇦
Hamad medical corporation, Doha, Qatar
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
Phase 1
Completed
- Conditions
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2015-06-17
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT02473887
Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 240
- Registration Number
- NCT02455687
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
"Palivizumab Therapy for RSV-bronchiolitis"
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2018-02-27
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 420
- Registration Number
- NCT02442427
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-11
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 1645
- Registration Number
- NCT02187614
- Locations
- 🇶🇦
Emergency Department, Hamad General Hospital., Doha, Qatar
Efficacy of Magnesium Sulfate in the Treatment of Bronchiolitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT02145520
- Locations
- 🇶🇦
Pediatric Emergency Center, Al Saad, Doha, Qatar
Comparison Among Erythropoietin Stimulating Agents
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 327
- Registration Number
- NCT02049346
- Locations
- 🇶🇦
Fahd Bin Jassem Dialysis Centre, Doha, Qatar
© Copyright 2024. All Rights Reserved by MedPath